Literature DB >> 34851477

Gene expression and oxidative stress markers profile associated with toxic metals in patients with renal cell carcinoma.

Heba H Tarabay1, Hassan Abol-Enein2, Amira Awadalla3, Wael I Mortada4, A F Abdel-Aziz1.   

Abstract

BACKGROUND: Toxic metals are associated with cancer progression. Studies have reported the relation between some toxic metals and renal cell carcinoma (RCC). METHODS AND
RESULTS: Blood levels of Cd and Pb were determined in 94 RCC patients (RCC group) and 91 matched controls as well as blood level of malondialdehyde (MDA) and catalase (CAT) activity as markers of oxidative stress and antioxidant, respectively. Gene expression of MAP kinase pathway (P38 and JNK), hypoxia-inducible factor 1-alpha (HIF1α), vascular endothelial growth factor (VEGF), cytochrome C oxidase subunit 6 (COX6), metallothionein (MT2A), and heat shock protein (HSP90AA1) were evaluated in the obtained tissue specimens. Blood Cd and Pb levels were significantly higher in RCC group comparing to control group with preferential significant increase of Cd in chromophobe RCC (chRCC) sub-type. MDA level was significantly higher and CAT activity was lower in the RCC compared to controls. The difference was evident only in chRCC. The expressions of genes were significantly increased in the cancer tissues than in non-cancerous tissues in RCC sub-types and there was a significant correlation between Cd levels and expression of genes VEGF, MT2A, P38 and JNK in chRCC group. Immunohistochemical staining of clear cell RCC tissues shows a marked expression of VEGF and HIF-1α.While COX6 staining show marked expression in chRCC.
CONCLUSIONS: There is a positive correlation between Cd toxicity and the development of RCC, especially chRCC sub-type. Cd is strongly incriminated in the pathogenesis of chRCC through the effort on some genes and oxidative stress markers.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cadmium; Gene expression; Lead; Oxidative stress; Renal cell carcinoma

Mesh:

Substances:

Year:  2021        PMID: 34851477     DOI: 10.1007/s11033-021-06944-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

Review 1.  Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinoma.

Authors:  Charlene M Mantia; David F McDermott
Journal:  Cancer       Date:  2019-09-18       Impact factor: 6.860

Review 2.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

Review 3.  Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach.

Authors:  Christophe Glorieux; Pedro Buc Calderon
Journal:  Biol Chem       Date:  2017-09-26       Impact factor: 3.915

4.  Quantitative and qualitative evaluation of toxic metals and trace elements in the tissues of renal cell carcinoma compared with the adjacent non-cancerous and control kidney tissues.

Authors:  Mahmoud Abdel-Gawad; Emad Elsobky; Mohamed Abdel-Hameed; Mona Abdel-Rahim; Ahmed Harraz; Ahmed A Shokeir; Bedeir Ali-El-Dein
Journal:  Environ Sci Pollut Res Int       Date:  2020-05-28       Impact factor: 4.223

5.  Angiogenesis of renal cell carcinoma: perfusion CT findings.

Authors:  Yan Chen; Jin Zhang; Jingrui Dai; Xiaoli Feng; Haizhen Lu; Chunwu Zhou
Journal:  Abdom Imaging       Date:  2009-09-11

6.  Identifying novel candidate biomarkers of RCC based on WGCNA analysis.

Authors:  Jin Deng; Wei Kong; Xiaoyang Mou; Shuaiqun Wang; Weiming Zeng
Journal:  Per Med       Date:  2018-09-27       Impact factor: 2.512

Review 7.  A compendium of mutational cancer driver genes.

Authors:  Francisco Martínez-Jiménez; Ferran Muiños; Inés Sentís; Jordi Deu-Pons; Iker Reyes-Salazar; Claudia Arnedo-Pac; Loris Mularoni; Oriol Pich; Jose Bonet; Hanna Kranas; Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nat Rev Cancer       Date:  2020-08-10       Impact factor: 60.716

Review 8.  Oxidative stress, aging, and diseases.

Authors:  Ilaria Liguori; Gennaro Russo; Francesco Curcio; Giulia Bulli; Luisa Aran; David Della-Morte; Gaetano Gargiulo; Gianluca Testa; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  Clin Interv Aging       Date:  2018-04-26       Impact factor: 4.458

9.  Malondialdehyde as a Marker of Oxidative Stress in Periodontitis Patients.

Authors:  Deepthi A Cherian; Tim Peter; Anjhana Narayanan; Sanupa S Madhavan; Sylvana Achammada; Gopinath Parakkat Vynat
Journal:  J Pharm Bioallied Sci       Date:  2019-05

10.  Epidemiology and Clinicopathological Profile of Renal Cell Carcinoma: A Review from Tertiary Care Referral Centre.

Authors:  Likhiteswer Pallagani; Gautam Ram Choudhary; Pandey Himanshu; Vijay K S Madduri; Mahendra Singh; Prateek Gupta; Nikita Shrivastava; Gaurav Baid; Rao Meenakshi; Nalwa Aasma; Puneet Pareek; Misra Sanjeev
Journal:  J Kidney Cancer VHL       Date:  2021-01-20
View more
  1 in total

1.  Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma.

Authors:  Tong Zhu; Tianyu Wang; Zijun Feng; Furong Gao; Jieping Zhang; Caixia Jin; Haibin Tian; Jingying Xu; Hao Chen; Qingjian Ou; Juan Wang; Guotong Xu; Lixia Lu
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.